Antibiotic Resistance in India: Drivers and Opportunities for Action

English version České info

Ramanan Laxminarayan and Ranjit Roy Chaudhury examine the factors encouraging the emergence of antibiotic resistance in India, the implications nationally and internationally, and what might be done to help.

Vyšlo v časopise: Antibiotic Resistance in India: Drivers and Opportunities for Action. PLoS Med 13(3): e32767. doi:10.1371/journal.pmed.1001974
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001974

Souhrn

Zdroje

1. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases. 2013;13(12):1057–98. Epub 2013/11/21. doi: 10.1016/S1473-3099(13)70318-9 24252483.

2. Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JP, Gupta U, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. The Indian journal of medical research. 2011;134 : 281–94. Epub 2011/10/12. 21985810; PubMed Central PMCID: PMC3193708.

3. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. Jama. 1999;281(1):61–6. 9892452.

4. Laxminarayan R, Matsoso P, Pant S, Brower C, Barter D, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2015;387 : 168–175. Published online Nov 18. doi: 10.1016/S0140-6736(15)00474-2 26603918

5. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerging Infectious Diseases. 2011;17(10):1791–8. Epub 2011/10/18. doi: 10.3201/eid1710.110655 22000347; PubMed Central PMCID: PMC3310682.

6. Holloway K, Mathai E, Sorensen T, Gray T. Community-based surveillance of antimicrobial use and resistance in resources -⁠ constrained settings: report on five pilot projects. Geneva: World Health Organization, 2009.

7. CDDEP. ResistanceMap Washington DC: Center for Disease Dynamics, Economics & Policy; 2015 [August 20, 2015]. http://www.resistancemap.org.

8. Datta S, Wattal C, Goel N, Oberoi JK, Raveendran R, Prasad KJ. A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital. The Indian journal of medical research. 2012;135(6):907–12. Epub 2012/07/25. 22825611; PubMed Central PMCID: PMC3410219.

9. CDDEP. The State of the World's Antibiotics, 2015. Washington DC: Center for Disease Dynamics, Economics & Policy, 2015.

10. Chatterjee D, Sen S, Begum SA, Adhikari A, Hazra A, Das AK. A questionnaire-based survey to ascertain the views of clinicians regarding rational use of antibiotics in teaching hospitals of Kolkata. Indian J Pharmacol. 2015;47(1):105–8. doi: 10.4103/0253-7613.150373 25821321; PubMed Central PMCID: PMCPMC4375802.

11. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–50. doi: 10.1016/S1473-3099(14)70780-7 25022435.

12. Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. BMJ. 2012;344:e1567. Epub 2012/04/12. doi: 10.1136/bmj.e1567 22491075.

13. Kanungo S, Mahapatra T, Bhaduri B, Mahapatra S, Chakraborty ND, Manna B, et al. Diarrhoea-related knowledge and practice of physicians in urban slums of Kolkata, India. Epidemiol Infect. 2014;142(2):314–26. doi: 10.1017/S0950268813001076 23659645.

14. World Bank. World Development Indicators. http://data.worldbank.org/indicator. 2015 [cited 2015 Accessed July 7th, 2015].

15. Roy N, Madhiwalla N, Pai SA. Drug promotional practices in Mumbai: a qualitative study. Indian journal of medical ethics. 2007;4(2):57–61. 18630221.

16. Kumar A, Biswal M, Dhaliwal N, Mahesh R, Appannanavar SB, Gautam V, et al. Point prevalence surveys of healthcare-associated infections and use of indwelling devices and antimicrobials over three years in a tertiary care hospital in India. J Hosp Infect. 2014;86(4):272–4. doi: 10.1016/j.jhin.2013.12.010 24613563.

17. Diggikar R. Pharmacies violating norms face FDA music: The Times of India; 2015 [cited 2015 Sep 20, 2015]. http://timesofindia.indiatimes.com/city/aurangabad/Pharmacies-violating-norms-face-FDA-music/articleshow/45942373.cms.

18. Wells WA, Ge CF, Patel N, Oh T, Gardiner E, Kimerling ME. Size and usage patterns of private TB drug markets in the high burden countries. PLoS ONE. 2011;6(5):e18964. doi: 10.1371/journal.pone.0018964 21573227; PubMed Central PMCID: PMC3087727.

19. Goswami N, Gandhi A, Patel P, Dikshit R. An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors. Perspectives in clinical research. 2013;4(2):130–5. doi: 10.4103/2229-3485.111797 23833738; PubMed Central PMCID: PMC3700327.

20. Bate R, Tren R, Mooney L, Hess K, Mitra B, Debroy B, et al. Pilot study of essential drug quality in two major cities in India. PLoS ONE. 2009;4(6):e6003. doi: 10.1371/journal.pone.0006003 19547757; PubMed Central PMCID: PMC2695555.

21. Rutgersson C, Fick J, Marathe N, Kristiansson E, Janzon A, Angelin M, et al. Fluoroquinolones and qnr genes in sediment, water, soil, and human fecal flora in an environment polluted by manufacturing discharges. Environmental science & technology. 2014;48(14):7825–32. doi: 10.1021/es501452a 24988042.

22. Johnning A, Moore ER, Svensson-Stadler L, Shouche YS, Larsson DG, Kristiansson E. Acquired genetic mechanisms of a multiresistant bacterium isolated from a treatment plant receiving wastewater from antibiotic production. Appl Environ Microbiol. 2013;79(23):7256–63. doi: 10.1128/AEM.02141-13 24038701; PubMed Central PMCID: PMC3837729.

23. Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A. 2015;112(18):5649–54. doi: 10.1073/pnas.1503141112 25792457; PubMed Central PMCID: PMCPMC4426470.

24. Laxminarayan R, Van Boeckel TP, Teillant A. The economic costs of withdrawing antimicrobial growth promoters from the livestock sector. Paris: Organization for Economic Cooperation and Development, 2015.

25. Kakkar M, Rogawski L. Antibiotic Use and Residues in Chicken Meat and Milk Samples from Karnataka and Punjab, India. New Delhi, India: Public Health Foundation of India, 2013.

26. Sahu R, Saxena P. Antibiotics in Chicken Meat. New Delhi, India: Centre for Science and Environment, 2014 July 2014. Report No.: Contract No.: PML/PR-48/2014.

27. Basnyat B. Antibiotic resistance needs global solutions. Lancet Infect Dis. 2014;14(7):549–50. doi: 10.1016/S1473-3099(14)70800-X 24964937.

28. Ghafur A. The Chennai Declaration: a solution to the antimicrobial resistance problem in the Indian subcontinent. Clin Infect Dis. 2013;56(8):1190. doi: 10.1093/cid/cis1224 23307765.

29. Lee JT, Agrawal S, Basu S, Glantz SA, Millett C. Association between smoke-free workplace and second-hand smoke exposure at home in India. Tob Control. 2014;23(4):308–12. doi: 10.1136/tobaccocontrol-2012-050817 23525121; PubMed Central PMCID: PMCPMC3701026.

30. Huttner B, Goossens H, Verheij T, Harbarth S, consortium C. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;10(1):17–31. doi: 10.1016/S1473-3099(09)70305-6 20129146.